Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation of its software, which ...
Please provide your email address to receive an email when new articles are posted on . Dronedarone was associated with lower incidence of permanent atrial fibrillation/atrial flutter, more return to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results